Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing processes and exploring innovations that could streamline the path from ...

The new Centre for Therapeutic Target Validation (CTTV) is just one of a new generation of public-private partnerships in drug discovery being set up across the world. But the scale and depth of ...

In the target validation studies ... impact of artificial intelligence in the acceleration of target discovery and drug repurposing. AI has simplified target identification and improved our ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies ...

The Small Molecule Drug Discovery Market size is expected to be worth around USD 121.8 billion by 2033 from USD 52.5 billion in 2023, growing at a CAGR of 8.8% ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

United Kingdom, 15 th January 2025: Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against ... The ...